Effect of surfactant dose on outcomes in preterm infants with respiratory distress syndrome: the OPTI-SURF study protocol
Introduction Respiratory distress syndrome is a condition seen in preterm infants primarily due to surfactant insufficiency. European guidelines recommend the dose and method of surfactant administration. However, in routine practice, clinicians often use a ‘whole vial’ approach to surfactant dosing...
Saved in:
| Main Authors: | Nicholas Longford, Chris Gale, Kevin Colin William Goss, Rachel Malone, Kirsty Ratcliffe |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2020-12-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/10/12/e038959.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Early administration of the second surfactant dose in preterm infants with severe respiratory distress syndrome
by: Nilgün Köksal, et al.
Published: (2009-12-01) -
Significance of surfactant proteins in respiratory distress syndrome in preterm infants
by: İ.A. Mirzayeva, et al.
Published: (2024-04-01) -
Surfactant therapy in late preterm infants: respiratory distress syndrome and beyond
by: Ozge Sürmeli-Onay, et al.
Published: (2012-06-01) -
Is there a necessity for multiple doses of surfactant for respiratory distress syndrome of premature infants?
by: Christos Tsakalidis, et al.
Published: (2012-08-01) -
Comment on “the efficacy of lung ultrasound scores-directed pulmonary surfactant treatment in preterm infants with respiratory distress syndrome”
by: Ling Zeng, et al.
Published: (2025-12-01)